Randall Thompson, MD, immediate past president of the American Society of Nuclear Cardiology (ASNC), explains two key advances in cardiac nuclear imaging.
 

The COVID lockdowns at the Shanghai plant began on March 31, and although the plant there has since resumed operations, they are not yet at 100% capacity.

The American Hospital Association is asking GE Healthcare to more fully apprise AHA’s nearly 5,000 member organizations of what the company is doing to help ameliorate the ongoing disruption in supplies of Omnipaque (iohexol).

Brain MRI of the choroid plexus, the main supplier of cerebrospinal fluid, can deliver independent biomarkers for Alzheimer’s disease without an assist from clinical tests for amyloid abnormality or neurodegeneration. 

The FDA has OK’d two subsidiaries of Los Angeles-based RadNet to sell medical AI software—one product for diagnosing breast cancer, the other for streamlining MRI prostate reporting workflows. 

Combining ensemble AI models with reads from breast radiologists of mixed experience levels can help health systems consistently diagnose malignant architectural distortion on mammography.

Structural brain abnormalities detected by MRI are among the risk factors the funded researchers will identify as novel biomarkers.

U.S. healthcare is now a solid week into the CT contrast shortage of ’22, and common themes are emerging in adaptations at local hospitals and imaging centers.